SignalHF vs DeepTek CXR Analyzer

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Implicity
VS
by DeepTek

AI Verdict

SignalHF is designed for predictive analytics, leveraging data from cardiac implantable electronic devices to forecast heart failure hospitalizations and enable proactive patient management. In contrast, DeepTek CXR Analyzer is a diagnostic assistance tool for radiologists, using AI to detect and highlight various pathologies on chest X-rays, including cardiac findings. While both utilize AI within the cardiology domain, their distinct data inputs and primary functions cater to different stages of patient care and clinical workflows.

Choose SignalHF if…

Choose SignalHF if your primary goal is to proactively prevent heart failure hospitalizations in patients with cardiac implantable electronic devices. This tool is ideal for cardiology practices seeking to leverage AI for continuous, manufacturer-agnostic monitoring of CIED data to identify high-risk patients and enable timely, personalized interventions.

View SignalHF →

Choose DeepTek CXR Analyzer if…

Choose DeepTek CXR Analyzer if your radiology department aims to significantly improve the efficiency and accuracy of chest X-ray interpretation. This AI-powered CADe solution is best suited for assisting radiologists in automatically detecting and highlighting a wide range of lung, pleural, and cardiac pathologies, thereby streamlining workflow and reducing diagnostic turnaround times.

View DeepTek CXR Analyzer →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature SignalHF DeepTek CXR Analyzer
Pricing Contact for pricing Global access pricing available for eligible public sector and not-for-profit healthcare providers in 138 low- and middle-income countries, offering unlimited ai analyses per connected x-ray unit, installation, user training, product updates, maintenance, and technical support via an annual subscription.
Deployment SaaS On-premise and Cloud offerings. The solution supports online, offline, and hybrid deployment.
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

DeepTek CXR Analyzer

DeepTek CXR Analyzer provides explicit features for seamless integration into existing radiology workflows, including DICOM-based PACS integration and intelligent segregation of scans. Its claims of reducing radiologist workload by 30-50% and boosting productivity by 2x-3x, along with user testimonials, indicate a strong focus on workflow efficiency and ease of use.

Clinical Value

SignalHF

SignalHF offers a unique predictive capability by identifying patients at risk of heart failure hospitalizations within 30 days, enabling early intervention and personalized care. This proactive approach to preventing critical adverse events, validated by studies like FORESEE-HF, provides a distinct and high-impact clinical value.

Pricing & Value

DeepTek CXR Analyzer

DeepTek CXR Analyzer offers a 'pay-per-use' pricing model, which provides greater transparency and flexibility for budgeting compared to SignalHF's unspecified 'contact for pricing' approach. This model can offer better value by aligning costs directly with usage.

Enterprise Readiness

DeepTek CXR Analyzer

DeepTek CXR Analyzer offers both cloud and on-premise deployment options, providing greater flexibility for diverse enterprise IT infrastructures. Its seamless DICOM-based PACS integration, broader international regulatory approvals, and reported deployment in over 500 hospitals and imaging centers demonstrate robust enterprise readiness.

Innovation

SignalHF

SignalHF stands out for its predictive AI algorithm that forecasts heart failure hospitalizations by analyzing multi-brand cardiac implantable electronic device data. This manufacturer-agnostic, preventative approach to a critical health outcome represents a more groundbreaking and transformative application of AI in healthcare.

Support & Docs

DeepTek CXR Analyzer

DeepTek CXR Analyzer explicitly provides a dedicated customer support email address and offers various resources like white papers and publications. While SignalHF mentions 'instructions for use,' DeepTek's clear and accessible support channels indicate a more comprehensive support infrastructure.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature SignalHF DeepTek CXR Analyzer
Name SignalHF DeepTek CXR Analyzer
Company Implicity DeepTek Medical Imaging Pvt
Primary Function Predicts heart failure hospitalizations within 30 days by analyzing data from various cardiac implantable electronic devices. AI-powered CADe solution for chest X-ray analysis, designed to assist radiologists by automatically detecting and highlighting suspicious regions across lung, pleural, and cardiac pathologies.
Categories Cardiology AI Cardiology AI, Radiology & Imaging AI
Specialties Cardiology Cardiology, Pulmonology, Radiology
Key Detections/Analysis Analyzes physiological data, demographics, lead measurements, episodes, and therapies from CIEDs to predict heart failure hospitalizations. Detection of 28 findings covering lung, pleural, cardiac pathologies, and hardware; automatic identification, categorization, and highlighting of suspicious regions of interest (ROIs).
Compatibility/Integration Manufacturer-agnostic compatibility with various CIEDs (pacemakers, ICDs, CRTs). Seamless DICOM-based PACS integration (on-premise or cloud); Compatible with various X-ray modalities (hospital, mobile, portable, handheld).

Videos

Demos, reviews, and walkthroughs featuring SignalHF and DeepTek CXR Analyzer.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

SignalHF is an FDA-cleared AI algorithm designed to predict heart failure hospitalizations within 30 days by analyzing data from cardiac implantable electronic devices, enabling early intervention and personalized care. DeepTek CXR Analyzer is an FDA-cleared AI-powered computer-assisted detection (CADe) solution for chest X-ray analysis, assisting radiologists by automatically detecting and highlighting suspicious regions across lung, pleural, and cardiac pathologies.
SignalHF analyzes physiological data, demographics, lead measurements, episodes, and therapies collected from various cardiac implantable electronic devices (CIEDs) such as pacemakers, ICDs, and CRTs. DeepTek CXR Analyzer processes DICOM-based chest X-ray images to identify and categorize suspicious regions of interest.
SignalHF is primarily designed to support Cardiology, focusing on heart failure management. DeepTek CXR Analyzer supports Cardiology, Pulmonology, and Radiology by assisting with the interpretation of chest X-rays for a wide array of findings.
SignalHF functions as a unified SaaS platform for centralizing cardiac implantable device data and generating automatic alerts for care teams. DeepTek CXR Analyzer offers seamless DICOM-based PACS integration, operating either on-premise or in the cloud, to automatically identify, categorize, and highlight suspicious regions on chest X-rays and send results back to PACS as secondary captures.
SignalHF generates automatic alerts for care teams based on risk scores, enabling early intervention and personalized care plans to potentially avert heart failure hospitalizations. DeepTek CXR Analyzer automatically identifies, categorizes, and highlights suspicious regions on chest X-rays, aiming to reduce radiologist workload by 30-50% and boost productivity by 2x-3x, thereby improving diagnostic accuracy.

Backers

Who funded each tool's parent company.

SignalHF

AI Tool Finder
AI-powered search. Results may not be comprehensive.